WO2016037698A1 - Antioxidant food composition in gel form - Google Patents
Antioxidant food composition in gel form Download PDFInfo
- Publication number
- WO2016037698A1 WO2016037698A1 PCT/EP2015/001807 EP2015001807W WO2016037698A1 WO 2016037698 A1 WO2016037698 A1 WO 2016037698A1 EP 2015001807 W EP2015001807 W EP 2015001807W WO 2016037698 A1 WO2016037698 A1 WO 2016037698A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- composition according
- content
- composition
- pomegranate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 235000013305 food Nutrition 0.000 title claims abstract description 7
- 230000003078 antioxidant effect Effects 0.000 title description 11
- 239000003963 antioxidant agent Substances 0.000 title description 7
- 239000000284 extract Substances 0.000 claims abstract description 31
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 26
- 240000002234 Allium sativum Species 0.000 claims abstract description 17
- 235000004611 garlic Nutrition 0.000 claims abstract description 17
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 13
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 13
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 12
- 235000013976 turmeric Nutrition 0.000 claims abstract description 12
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 10
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims abstract description 10
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 9
- 239000003349 gelling agent Substances 0.000 claims abstract description 7
- 229940094952 green tea extract Drugs 0.000 claims abstract description 7
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 7
- 229940109529 pomegranate extract Drugs 0.000 claims abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000004792 oxidative damage Effects 0.000 claims abstract description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 3
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 3
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 3
- 201000011510 cancer Diseases 0.000 claims description 16
- 239000011669 selenium Substances 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- 239000000499 gel Substances 0.000 claims description 7
- 241000219784 Sophora Species 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 244000215068 Acacia senegal Species 0.000 claims description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 4
- 235000010489 acacia gum Nutrition 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical group OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 235000013525 pomegranate juice Nutrition 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 241000206672 Gelidium Species 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 230000007170 pathology Effects 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 229930003761 Vitamin B9 Natural products 0.000 claims 1
- 235000019159 vitamin B9 Nutrition 0.000 claims 1
- 239000011727 vitamin B9 Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 239000002775 capsule Substances 0.000 abstract description 3
- 244000046101 Sophora japonica Species 0.000 abstract description 2
- 235000010586 Sophora japonica Nutrition 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 description 15
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 8
- 235000009569 green tea Nutrition 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000012754 curcumin Nutrition 0.000 description 4
- 239000004148 curcumin Substances 0.000 description 4
- 229940109262 curcumin Drugs 0.000 description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 4
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 241000219991 Lythraceae Species 0.000 description 3
- 235000014360 Punica granatum Nutrition 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000002206 flavan-3-ols Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- 108010092760 Alliin lyase Proteins 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 244000308180 Brassica oleracea var. italica Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241001083505 Punica Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007172 age related pathology Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical class OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000002012 ayurvedic medicine Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 150000001944 cysteine derivatives Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000001173 tumoral effect Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to the field of cancer prevention and, more specifically, to a specific gel composition for oral administration.
- Cancer is a disease characterized by an abnormally large cell proliferation (tumor) within a normal tissue of the body, in such a way that the survival of the latter, comes from it. to be threatened.
- the cells of this tumor generally derive from the same clone; which clone is comparable to the cancer initiating cell which has acquired certain characteristics allowing it to divide indefinitely.
- metastases some tumor cells are likely to migrate into the body and thus form what is called metastases.
- Cancer is a general term for a disease for which certain cells of an organism exhibit abnormal behavior characterized by:
- Cells associated with cancer are referred to as "cancerous” or “tumoral” and can form a malignant tumor (a neoplasm) or spread through the body.
- the risk factors for cancer are multiple and can be internal (familial, spontaneous mutation, etc.), and / or external (diet, exposure to infectious agents or carcinogens or conditions such as irradiation, etc. .).
- FIREPLACE REMPLACEMENT (RULE 26) If the impact of internal factors is not negligible, especially with hormonal or epigenetic factors; scientific studies associate only 5 to 10% of cancer cases with genetic factors, 25 to 30% for smoking, 30 to 35% for diets (including alcohol), 15 to 20% for infections, and 10 to 25% to other factors (ionizing radiation, stress, physical activity, environmental pollution).
- Fruit and vegetable consumption has been shown to have a protective effect on cancers of the upper aerodigestive tract (esophagus, oral cavity, larynx and pharynx), cancers of the stomach and lungs (for fruits only). It should also be noted that fruits and vegetables, which are low in calories, contribute to the maintenance of normal body weight and the prevention of overweight and obesity.
- the inventors have now developed a food composition in gel form, which comprises at least:
- the inventors have been able to demonstrate that such a food composition, intended for oral intake, despite its very high antioxidant content could be in the form of a gel.
- the inventors have observed that because of its gelled form, the bioavailability of curcumin present in the composition is significantly improved.
- FIRE REPLACEM ENT (RULE 26) which daily intake is obviously necessary to produce its preventive effects over time.
- turmeric (Curcuma longa) is a perennial rhizomatous herbaceous plant of the genus Turmeric of the family Zingiberaceae native to southern Asia. He has been known in the West since ancient times and described by Dioscorides in his Materia Medica.
- Turmeric is recognized in the West for its antioxidant properties by which it helps the body fight against stress and maintain the effectiveness of natural defenses. It has also been used for a very long time as an anti-inflammatory by Indian Ayurvedic medicine and is probably the strongest natural anti-inflammatory identified to date.
- curcumin The active ingredient of turmeric, curcumin, is thus the subject of active research. This molecule is able to inhibit in vitro the growth of a very large number of xancers: colon, liver, stomach, ovaries, breast, leukemia among others.
- the extract used turmeric corresponds to the rhizome of the latter which comprises from 0.5 to 3% by weight of curcominoids distributed between curcumin (0.4 to 2.2%), demethoxycurcumin (0, 1 to 1% ).
- the content of the composition according to the invention in extract of turmeric rhizome is between 1 and 3%, preferably between 1.5 and 2%.
- the Japanese Sophora or Styphnolobium japonicum, is a tree species of the family Fabaceae.
- the flower of the latter has the particularity to include flavonoids in quantity, which consist mainly of quercetin, rutin, isorhamnetin
- FLEI LLE OF REM PLACEM ENT (REG 26) and kaempferol.
- One of the first benefits of these molecules is their antioxidant activity, able to neutralize free radicals responsible for part of the aging and alteration of the body.
- the Sophora flower from Japan has the advantage of containing up to 15 to 20% rutin.
- the content of the composition according to the invention in Sophora flower extract from Japan is between 1 and 3%, preferably between 1.5 and 2%.
- Pomegranate is the fruit of the pomegranate tree, Punica granat, which belongs to the family Lythraceae and is found over a wide geographical area stretching from western Asia to central Asia. . The latter is thus a good source of dietary fiber, folate, and also a very good source of: vitamin C.
- the pomegranate aril contains in addition flavanols (or catechins) and; flavanol dimers (procyanidols), as well as a large number of particularly effective polyphenols, to which presumably its beneficial effects on health can be attributed.
- the content of the composition according to the invention in pomegranate extract is between 2 and 10%, preferably between 3 and 7%, or between 4 and 6%.
- this pomegranate extract we prefer to use pomegranate juice.
- the tea tree also called tea, like the infusion of its leaves, is a species of shrubs from the family of theaeeae. It is native to the Far East and is widely grown for its leaves which, once dried and more or less oxidized, are used for the preparation by infusion of this essential drink.
- Green tea is a particular variety of tea related to the preparation of tea leaves once harvested. Green tea is in fact a tea with very little oxidation during its manufacture, which allows to keep intact its properties.
- green tea The properties of green tea are multiple: rich in tannins, it is these antioxidant polyphenols that give tea its aroma and bitter taste. Green tea also contains vitamin C. But what sets green tea apart is
- FIRE I LLE OF REM PLACEM ENT (RULE 26) it contains a catechin called epigallocatechin EPGC or epigallocatechin-3-gallate (EGCG).
- EPGC has properties far more powerful than those of a simple antioxidant.
- Green tea (green because unfermented) contains ten times more EPGC than black tea and 2.5 times more than Oolong tea.
- caffeine theine
- Tea also contains teaanne, a glutamate-like amino acid that has a soothing effect that inhibits the caffeine's hypertensive effect.
- the content of the composition according to the invention in green tea extract is between 1 and 5%, preferably between 2 and 4%, or between 2.5 and 3%.
- a liquid green tea extract preferably a concentrated green tea extract which will comprise from 15 to 45% of dry matter, preferably from 25 to 35% by weight. dry matter.
- the one that is cultivated is a perennial monocotyledonous vegetable plant whose bulbs, with an odor and a strong taste, are often used as a condiment in cooking.
- a head of garlic is made up of several garlic cloves or garlic:
- Various studies show that regular consumption of a clove of garlic (3 g) per day would reduce by half the risk of cancer of the stomach, colon and rectum. This action would result in particular from the alliine, which is a sulfoxide and which is a derivative of cysteine.
- the alliinase enzyme When fresh garlic is crushed or chopped, this alliin is converted by the alliinase enzyme into allicin which is responsible for the aroma of fresh garlic.
- the content of the composition according to the invention in garlic bulb extract is between 0.01 and 0.5%, preferably between 0.01 and 0.05%.
- the content of the composition according to the invention in broccoli extract is between 1 and 5%, preferably between 2 and 4%, or between 2.5 and 3%.
- this broccoli extract it will be preferred to use a dry extract, and especially an atomized extract.
- this atomized extract comprises particles having a diameter of less than 1 ⁇ .
- Vitamin B 6 is involved in the metabolism of homocysteine whose deficiency causes a significant decrease in tone. In connection with the nervous system, vitamin B 6 also participates in the biosynthesis of serotonin and its recommended daily intake (RDA) is 1.4 mg according to the directive 2008/100 / CE.
- RDA recommended daily intake
- the composition according to the invention has a vitamin B 6 content is between 0.01 and 0.05%, preferably between 0.01 and 0.03%. This proportion is adapted so that the setting of the composition according to the invention is close to the AJR without risking (too) exceed it.
- “Gelling agent” means an agent which makes it possible to give the composition according to the invention the consistency of a gel.
- Such agents are well known to those skilled in the art and include gum arabic (or gum acacia), xanthan gum, gelatin, pectin, alginates, carrageenans, or agar agar.
- the content of gelling agent of the composition according to the invention is dependent on the gelling agent used and can be simply adapted by those skilled in the art. It is typically greater than 0.1%, 0.5% and less than 10% or 5%.
- composition according to the invention may further comprise different constituents with antioxidant or stimulating properties.
- selenium which belongs to the family of chalcogenes, of symbol Se and atomic number 34 is preferably added to the latter.
- Selenium is a trace element constituting selenoproteins including the intracellular principaDantioxidant, glutathione peroxidase. It is found in kidneys of pork, beef, garlic, fish and molluscs. Western nutrition largely meets the daily needs of this element, but it is impossible to predict body levels of selenium from dietary intake because its use and retention are dependent on the presence of folic acid, vitamin B12 and negatively affected by the presence of homocysteine.
- the selenium used will be in the form of a yeast extract (eg Saccharomyces cerevisiae) enriched in selenium. This enrichment corresponds to a concentration of the order of 1500 to 3000 g of selenium per gram of extract.
- yeast extract eg Saccharomyces cerevisiae
- selenium present in this extract is in the form of seleniomethionine and is in the form of a dry extract.
- the content of the composition according to the invention has a content of yeast extract enriched with selenium between between 0.1 and 0.5%, preferably between 0.1 and 0.3%.
- composition according to the invention will further preferably comprise vitamin B 9 which is essential for limiting cognitive decline and for preventing the onset of age-related pathologies such as Alzheimer's disease.
- the recommended daily intake (AIR) of vitamin B is 200 ⁇ g according to Directive 2008/100 / EC.
- the composition according to the invention has a vitamin B 9 content between 0.001 and 0.005%, preferably between 0.001 and 0.003%. This proportion is adapted so that the setting of the composition according to the invention is close to the AIR without risking to (excessively) exceed it.
- the composition according to the invention may furthermore comprise acidifiers, among which citric acid.
- the acidifying content of the composition according to the invention may reach 2%, but will preferably be less than or equal to 1%.
- composition according to the invention may comprise at least one sweetener.
- sweeteners include, among others, sucralose, stevia extract, xylitol, aspartame, glucose syrup, fructooligosaccharide syrup, maltitol powder or syrup, acesulfame potassium, fructooligosaccharide and sodium cyclamate.
- composition according to the invention will also comprise at least one preservative.
- preservatives mention may be made of potassium sorbate, sodium benzoate or ascorbyl palmitate (antioxidant).
- composition according to the invention may comprise a texturing agent such as glycerine.
- a second subject of the invention relates to a pod containing the composition in gel form according to the invention.
- the user can simply consume the required dose and, if desired, combine or dissolve in a glass of water.
- a third object according to the invention corresponds to the use of a composition as described above for the prevention of pathologies associated with oxidative damage due to free radicals, such as cancers, in a subject.
- cancer oral cancer or cancer of the digestive tract is preferably meant.
Abstract
The present invention relates to a food composition in gel form including at least a turmeric rhizome extract, a Sophora japonica flower extract, a pomegranate extract, a green tea extract, a garlic bulb extract, a broccoli extract, vitamin B6 and a gelling agent. The invention also relates to a capsule including a composition of this kind in gel form and to the use of a composition of this kind for preventing diseases associated with oxidative damage due to free radicals such as cancers.
Description
COMPOSITION ALIMENTAIRE ANTIOXYDANTE SOUS FORME DE GEL ANTIOXIDIZING FOOD COMPOSITION IN THE FORM OF GEL
La présente demande internationale revendique la priorité de la demande de brevet Français FR 14/02031 déposée en date du 11 septembre 2015 et dont le contenu est incorporée à celui de la présente demande internationale par référence. The present international application claims the priority of the French patent application FR 14/02031 filed on September 11, 2015 and the contents of which are incorporated in the present international application by reference.
Domaine de L'invention Field of the invention
La présente invention concerne le domaine de la prévention du cancer et, plus spécifiquement, une composition sous forme de gel spécifique et destinée à une prise orale. The present invention relates to the field of cancer prevention and, more specifically, to a specific gel composition for oral administration.
Art antérieur de l'invention Prior art of the invention
Le cancer est une maladie caractérisée par une prolifération cellulaire (tumeur) Anormalement importante au sein d'un tissu normal de l'organisme, de telle manière que la survie de ce dernier, en vient . à être menacée. Les cellules de cette tumeur dérivent en général toutes d'un même clone ; lequel clone est assimilable à la cellule initiatrice de cancer qui a acquis certaines caractéristiques lui permettant de se diviser indéfiniment. En fonction de l'évolution de la maladie, certaines cellules tumorales sont susceptibles de migrer dans l'organisme et de former ainsi ce que l'on appelle des métastases. Cancer is a disease characterized by an abnormally large cell proliferation (tumor) within a normal tissue of the body, in such a way that the survival of the latter, comes from it. to be threatened. The cells of this tumor generally derive from the same clone; which clone is comparable to the cancer initiating cell which has acquired certain characteristics allowing it to divide indefinitely. Depending on the evolution of the disease, some tumor cells are likely to migrate into the body and thus form what is called metastases.
Le terme « Cancer » est un terme général qui désigne une maladie pour lesquelles certaines cellules d'un organisme adoptent un comportement anormal caractérisé par : The term "Cancer" is a general term for a disease for which certain cells of an organism exhibit abnormal behavior characterized by:
• une capacité proliférative qui n'est plus limitée (croissance à l'infini) ; • a proliferative capacity that is no longer limited (growth to infinity);
• la disparition du phénomène d'apoptose (mort cellulaire); • the disappearance of the phenomenon of apoptosis (cell death);
• et l'acquisition d'un pouvoir invasif et de production de métastases. • and the acquisition of invasive power and the production of metastases.
Les cellules associées à un cancer sont qualifiées de « cancéreuses » ou « tumorales » et elles peuvent former une tumeur maligne (un néoplasme) ou se propager à travers le corps. Cells associated with cancer are referred to as "cancerous" or "tumoral" and can form a malignant tumor (a neoplasm) or spread through the body.
Les facteurs de risques au cancer sont multiples et peuvent être internes (familial, mutation spontanée, etc.), et/ou externes (alimentation, exposition à des agents infectieux ou à des substances cancérigènes ou à des conditions telles que l'irradiation, etc.). The risk factors for cancer are multiple and can be internal (familial, spontaneous mutation, etc.), and / or external (diet, exposure to infectious agents or carcinogens or conditions such as irradiation, etc. .).
FEU I LLE DE REM PLACEMENT (RÈG LE 26)
Si l'impact des facteurs internes n'est pas négligeable, avec notamment dés facteurs hormonaux ou épigénétiques ; des études scientifiques n'associent que 5 à 10 % des cas de cancer à des facteurs génétiques contre 25 à 30 % au tabagisme, 30 à 35 % aux régimes alimentaires (dont l'alcool), 15 à 20 % aux infections, et 10 à 25 % aux autres facteurs (rayons ionisants, stress, activités physique, pollution de l'environnement). FIREPLACE REMPLACEMENT (RULE 26) If the impact of internal factors is not negligible, especially with hormonal or epigenetic factors; scientific studies associate only 5 to 10% of cancer cases with genetic factors, 25 to 30% for smoking, 30 to 35% for diets (including alcohol), 15 to 20% for infections, and 10 to 25% to other factors (ionizing radiation, stress, physical activity, environmental pollution).
Durant la dernière décennie, plusieurs types de cancers semblent en augmentation, si dans certains cas cette progression est facilement liée à des facteurs de risqué identifiés (tabac, alcool, polluants industriels reconnus cancérigènes, obésité,, sédentarité, exposition au soleil) dans certains cas il est difficile d'attribuer à des facteurs précis l'augmentation observée. L'amélioration des outils de diagnostic et le vieillissement de la population expliquent une part importante de la progression de l'incidence de certains cancers. À l'inverse une étude de l'Institut de veille sanitaire montre que les cancers.de l'estomac, de l'œsophage (chez l'homme), du col de l'utérus et le lymphome hodgkinien ont régressé entre 1980 et 2000. During the last decade, several types of cancers seem to be increasing, if in some cases this progression is easily linked to identified risk factors (tobacco, alcohol, recognized carcinogenic industrial pollutants, obesity, inactivity, sun exposure) in certain cases. it is difficult to attribute the observed increase to specific factors. The improvement of diagnostic tools and the aging of the population explain a large part of the increase in the incidence of certain cancers. Conversely, a study conducted by the French Institute for Public Health Surveillance shows that cancers of the stomach, esophagus (in humans), the cervix and Hodgkin's lymphoma have declined between 1980 and 2000 .
La doublé prise de conscience actuelle de cette forte incidence du cancer associée à notre mode de vie moderne ont amené à une réflexion visant à adapter notre mode de vie en vue de mieux se prémunir contre cette maladie. The current double awareness of this high incidence of cancer associated with our modern lifestyle has led to a reflection to adapt our way of life to better guard against this disease.
Ces dernières années, il est apparu que le cancer, ou tout du moins certains cancers, touchait avec une moindre incidence certaines sous-populations. Si cette moindre sensibilité a pu parfois s'expliquer par des causes internes (génétiques), des causes externes et notamment alimentaires l'ont parfois expliquées. In recent years, it has become apparent that cancer, or at least some cancers, has a lower incidence of certain sub-populations. Although this lesser sensitivity could sometimes be explained by internal (genetic) causes, external and especially food causes have sometimes explained it.
Il est ainsi apparu que la consommation de fruits et légumes exerce un effet protecteur probable sur les cancers des voies aérodigestives supérieures (œsophage, cavité buccale, larynx et pharynx), les cancers de l'estomac et du poumon (pour les fruits seulement). A noter en outre que, les fruits et légumes, faibles en calories, participent au maintien d'un poids corporel normal et à la prévention du surpoids et de l'obésité. Fruit and vegetable consumption has been shown to have a protective effect on cancers of the upper aerodigestive tract (esophagus, oral cavity, larynx and pharynx), cancers of the stomach and lungs (for fruits only). It should also be noted that fruits and vegetables, which are low in calories, contribute to the maintenance of normal body weight and the prevention of overweight and obesity.
En outre, il est apparu qu'une alimentation riche en fibres (céréales complètes, fruits, légumes, légumineuses) étaient associée à un moindre risque de développer un cancer colorectal (niveau de preuve probable). In addition, it was found that a diet high in fiber (whole grains, fruits, vegetables, legumes) was associated with a lower risk of developing colorectal cancer (probable level of evidence).
FEU ILLE DE REMPLACEMENT (RÈGLE 26)
Au-delà de ces généralités, certains composants ont pu être associés à des actions anticancéreuses comme le curcuma (du fait de la curcumine). FIRE REPLACEMENT ISLAND (RULE 26) Beyond these generalities, certain components could be associated with anticancer actions such as turmeric (because of curcumin).
Partant de ces résultats différents compléments alimentaires à vocation préventive à rencontre du cancer ont été développés, soit sous forme de poudre, soit sous forme de gélules. On the basis of these results, various dietary supplements with a preventive function against cancer have been developed, either in the form of powder or in the form of capsules.
Descriptif de l'invention Description of the invention
Les inventeurs ont maintenant mis au point une composition alimentaire sous forme de gel, laquelle comprend au moins : The inventors have now developed a food composition in gel form, which comprises at least:
un extrait de rhizome de curcuma ; an extract of turmeric rhizome;
- un extrait de fleurs de Sophora du Japon ; - an extract of Sophora flowers from Japan;
- un extrait de grenade ; - a pomegranate extract;
- un extrait de thé vert ; - green tea extract
- un extrait de bulbe d'ail ; - an extract of bulb of garlic;
- un extrait de brocoli ; - an extract of broccoli;
- de la vitamine B6 ; et - vitamin B6; and
- un agent gélifiant. a gelling agent.
Les inventeurs ont pu mettre en évidence qu'une telle composition alimentaire, destinée à une prise orale, malgré sa teneur en antioxydants très élevée pouvait se trouver sous forme de gel. The inventors have been able to demonstrate that such a food composition, intended for oral intake, despite its very high antioxidant content could be in the form of a gel.
En outre, et de façon inattendue, les inventeurs ont pu observer que du fait de sa forme gélifiée, la biodisponibilité de la curcumine présente au sein de la composition s'en trouve très nettement améliorée. In addition, and unexpectedly, the inventors have observed that because of its gelled form, the bioavailability of curcumin present in the composition is significantly improved.
L'avantage d'une telle forme étant qu'elle a montré une perturbation nettement moindre du transit chez ses utilisateurs qu'une composition sous forme de poudre. The advantage of such a form is that it has shown a significantly lower disturbance of transit in its users than a composition in powder form.
De surcroît, les utilisateurs l'ont consommé bien plus facilement qu'une composition sous forme de gélule, associée plus fortement à Une forme « médicale » et donc à la maladie. In addition, the users consumed it much more easily than a composition in capsule form, associated more strongly with a "medical" form and therefore with the disease.
Finalement, les utilisateurs ont appréciés les qualités organoleptiques de la composition selon l'invention, ce qui a grandement facilité sa prise quotidienne, Finally, the users appreciated the organoleptic qualities of the composition according to the invention, which greatly facilitated its daily intake,
FEU ILLE DE REMPLACEM ENT (RÈGLE 26)
laquelle prise quotidienne est bien évidemment nécessaire pour produire ses effets préventifs avec le temps. FIRE REPLACEM ENT (RULE 26) which daily intake is obviously necessary to produce its preventive effects over time.
Pour ce qui est des composants de celle-ci, on trouve tout d'abord le curcuma (Curcuma longa) est une plante herbacée rhizomàteuse vivace du genre Curcuma de la famille des Zingibéracées originaire du sud de l'Asie. Il est connu en Occident depuis l'Antiquité et décrit par Dioscoride dans ses Materia Medica. In terms of its components, turmeric (Curcuma longa) is a perennial rhizomatous herbaceous plant of the genus Turmeric of the family Zingiberaceae native to southern Asia. He has been known in the West since ancient times and described by Dioscorides in his Materia Medica.
Le curcuma est reconnu en Occident pour ses propriétés antioxydantes par lesquelles il aide l'organisme à lutter contre le stress et à maintenir l'efficacité' des défenses naturelles. Il est également utilisé depuis très longtemps comme anti- inflammatoire par la médecine ayurvédique indienne et c'est probablement l'anti- inflammatoire naturel le plus puissant identifié à ce jour. Turmeric is recognized in the West for its antioxidant properties by which it helps the body fight against stress and maintain the effectiveness of natural defenses. It has also been used for a very long time as an anti-inflammatory by Indian Ayurvedic medicine and is probably the strongest natural anti-inflammatory identified to date.
' Maintenant, il a été mis en évidence qu'il peut jouer aussi un rôle dans la prévention du cancer et à âge égal, les Indiens ont huit fois moins de cancers du poumon que les Occidentaux, neuf fois moins de cancers du côlon, 5 fois moins de cancers du sein et jusqu'à dix fois moins de cancers du rein. Un des éléments pouvant expliquer cette différence pourrait être attribuable à leur consommation élevée de curcuma, laquelle est en moyenne de 1,5 à 2 g de curcuma par jour (l'équivalent d'un quart à une demi-cuillère à café). ' Now it has been shown that it can also play a role in cancer prevention and at the same age, Indians have eight times less lung cancer than Westerners, nine times less colon cancer, 5 times fewer breast cancers and up to ten times fewer kidney cancers. One of the factors that may explain this difference could be attributable to their high consumption of turmeric, which averages 1.5 to 2 g of turmeric per day (the equivalent of a quarter to a half a teaspoon).
: Le principe actif du curcuma, la curcumine, est ainsi l'objet de recherches actives. Cette molécule se montre capable d'inhibe in vitro la croissance d'un très grand nombre dexancers : côlon, foie, estomac, ovaires, sein, leucémie entre autres. : The active ingredient of turmeric, curcumin, is thus the subject of active research. This molecule is able to inhibit in vitro the growth of a very large number of xancers: colon, liver, stomach, ovaries, breast, leukemia among others.
: L'extrait utilisé de curcuma correspond au rhizome de ce dernier qui comprend de 0,5 à 3% en poids de curcominoïdes répartis entre la curcumine (0,4 à 2,2%), la déméthoxycurcumine (0, 1 à 1%). The extract used turmeric corresponds to the rhizome of the latter which comprises from 0.5 to 3% by weight of curcominoids distributed between curcumin (0.4 to 2.2%), demethoxycurcumin (0, 1 to 1% ).
: Avantageusement, la teneur de la composition selon l'invention en extrait de rhizome de curcuma est comprise entre 1 et 3%, de préférence entre 1,5 et 2%. Advantageously, the content of the composition according to the invention in extract of turmeric rhizome is between 1 and 3%, preferably between 1.5 and 2%.
Le Sophora du Japon, ou Styphnolobium japonicum, est une espèce d'arbre de la famille des Fabaceae. The Japanese Sophora, or Styphnolobium japonicum, is a tree species of the family Fabaceae.
La fleur de ce dernier présente la particularité de comprendre des flavonoïdes en quantité, lesquels consistent principalement en la quercétine, la rutine, l'isorhamnétine The flower of the latter has the particularity to include flavonoids in quantity, which consist mainly of quercetin, rutin, isorhamnetin
FEUI LLE DE REM PLACEM ENT (RÈG LE 26)
et le kaempférol. Un des premiers bienfaits de ces molécules consistent en leur activité antioxydante, à même de neutraliser les radicaux libres responsables pour partie du vieillissement et de l'altération de l'organisme. La fleur de Sophora du Japon présente l'avantage de renfermer jusqu'à 15 à 20% de rutine. FLEI LLE OF REM PLACEM ENT (REG 26) and kaempferol. One of the first benefits of these molecules is their antioxidant activity, able to neutralize free radicals responsible for part of the aging and alteration of the body. The Sophora flower from Japan has the advantage of containing up to 15 to 20% rutin.
Avantageusement, la teneur de la composition selon l'invention en extrait de fleur de Sophora du Japon est comprise entre 1 et 3%, de préférence entre 1,5 et 2%. Advantageously, the content of the composition according to the invention in Sophora flower extract from Japan is between 1 and 3%, preferably between 1.5 and 2%.
La grenade, quant à elle, est le fruit du grenadier, ou Punica granat m, qui appartient à la famille des Lythracées et que l'on trouve sur un large domaine géographique qui s'étend de l'Asie occidentale à l'Asie centrale. Cette dernière est ainsi une bonne source de fibres alimentaires, de folate, et également une très bonne source de: vitamine C. L'arille de la grenade contient en outre des flavanols (ou catéchines) et des; dimères de flavanols (des procyanidols), de même qu'un grand nombre de polyphénols particulièrement efficaces et auxquels on peut vraisemblablement attribuer ses effets bénéfiques pour la santé. Pomegranate is the fruit of the pomegranate tree, Punica granat, which belongs to the family Lythraceae and is found over a wide geographical area stretching from western Asia to central Asia. . The latter is thus a good source of dietary fiber, folate, and also a very good source of: vitamin C. The pomegranate aril contains in addition flavanols (or catechins) and; flavanol dimers (procyanidols), as well as a large number of particularly effective polyphenols, to which presumably its beneficial effects on health can be attributed.
Tous ces composants contribuent à doter le jus de grenade de propriétés antioxydantes des plus intéressantes. All these components contribute to providing pomegranate juice with some of the most interesting antioxidant properties.
. Avantageusement, la teneur de la composition selon l'invention en extrait de grenade èst comprise entre 2 et 10%, de préférence entre 3 et 7%, voir entre 4 et 6%. Maintenant, cet pour ce qui est de cet extrait de grenade, on préférera utiliser le jus de grenade. . Advantageously, the content of the composition according to the invention in pomegranate extract is between 2 and 10%, preferably between 3 and 7%, or between 4 and 6%. Now, for this pomegranate extract, we prefer to use pomegranate juice.
Le théier (Camellia sinensis), appelé aussi thé, comme l'infusion de ses feuilles, est Une espèce d'arbustes de là famille des Théaeées. Il est originaire d'Extrême-Orient et est largement cultivé pour ses feuilles qui, une fois séchées et plus ou moins oxydées, servent à la préparation par infusion de cette boisson incontournable. The tea tree (Camellia sinensis), also called tea, like the infusion of its leaves, is a species of shrubs from the family of theaeeae. It is native to the Far East and is widely grown for its leaves which, once dried and more or less oxidized, are used for the preparation by infusion of this essential drink.
Le thé vert correspond à une variété particulière de thé liée à la préparation des feuilles de thé une fois récoltées. Le thé vert est en fait un thé très peu oxydé lors de sa fabrication, laquellè permet de conserver ainsi intactes ses propriétés. Green tea is a particular variety of tea related to the preparation of tea leaves once harvested. Green tea is in fact a tea with very little oxidation during its manufacture, which allows to keep intact its properties.
. Les propriétés du thé vert sont multiples : riche en tanins, ce sont ces polyphénols antioxydants qui donnent au thé son arôme et son goût amer particulier. Le thé vert contient également de la vitamine C. Mais ce qui démarque le thé vert des autres, c'est . The properties of green tea are multiple: rich in tannins, it is these antioxidant polyphenols that give tea its aroma and bitter taste. Green tea also contains vitamin C. But what sets green tea apart is
FEU I LLE DE REM PLACEM ENT (RÈG LE 26)
qu'il contient une catéchine nommée épigallocatéchine EPGC ou encore épigallocatéchine-3-gallate (EGCG). L'EPGC possède des propriétés bien plus puissantes que celles d'un simple antioxydant. Le thé vert (vert car non fermenté) contient ainsi dix fois plus d'EPGC que le thé noir et 2,5 fois plus que le thé Oolong. Quant au taux de caféine (théine), il est semblable à celui du thé noir soit 20-90 mg par tasse mais ses effets excitants sont atténués par la présence des tanins. Le thé contient également de la théanjne, un acide aminé analogue au glutamate, qui a un effet apaisant qui inhibe l'effet hypertenseur de la caféine. FIRE I LLE OF REM PLACEM ENT (RULE 26) it contains a catechin called epigallocatechin EPGC or epigallocatechin-3-gallate (EGCG). EPGC has properties far more powerful than those of a simple antioxidant. Green tea (green because unfermented) contains ten times more EPGC than black tea and 2.5 times more than Oolong tea. As for the caffeine (theine), it is similar to that of black tea is 20-90 mg per cup but its exciting effects are mitigated by the presence of tannins. Tea also contains teaanne, a glutamate-like amino acid that has a soothing effect that inhibits the caffeine's hypertensive effect.
Là encore, tous ces composants contribuent à doter le thé vert de propriétés antioxydantes puissantes et adaptées à prévenir les dommages des stress oxydatifs. Here again, all these components contribute to providing green tea with powerful antioxidant properties that are suitable for preventing damage from oxidative stress.
Avantageusement, la teneur de la composition selon l'invention en extrait de thé vert est comprise entre 1 et 5%, de préférence entre 2 et 4%, voir entre 2,5 et 3%. Maintenant, et pour ce qui est de cet extrait de thé vert, on préférera utiliser un extrait liquide de thé vert, de préférence un extrait de thé vert concentré lequel comprendra de 15 à 45% de matière sèche, de préférence de 25 à 35% de matière sèche. Advantageously, the content of the composition according to the invention in green tea extract is between 1 and 5%, preferably between 2 and 4%, or between 2.5 and 3%. Now, and for this green tea extract, it will be preferable to use a liquid green tea extract, preferably a concentrated green tea extract which will comprise from 15 to 45% of dry matter, preferably from 25 to 35% by weight. dry matter.
Pour l'ail, celui qui est cultivé (Allium sativum) est une plante potagère vivace monocotylédone dont les bulbes, à l'odeur et au goût fort, sont souvent employés comme condiment en cuisine. Une tête d'ail se compose de plusieurs caïèux ou gousses d'ail: Différentes études établissent que la consommation régulière d'une gousse d'ail (3 g) par jour réduirait de moitié le risque de cancer de l'estomac, du colon ét du rectum. Cette action résulterait notamment de l'alliine, qui est un sulfoxyde et qui constitue un dérivé de la cystéine. Lorsque de l'ail frais est écrasé ou haché, cet alliine est convertit par l'enzyme alliinase en allicine qui est responsable de l'arôme de l'ail frais. For garlic, the one that is cultivated (Allium sativum) is a perennial monocotyledonous vegetable plant whose bulbs, with an odor and a strong taste, are often used as a condiment in cooking. A head of garlic is made up of several garlic cloves or garlic: Various studies show that regular consumption of a clove of garlic (3 g) per day would reduce by half the risk of cancer of the stomach, colon and rectum. This action would result in particular from the alliine, which is a sulfoxide and which is a derivative of cysteine. When fresh garlic is crushed or chopped, this alliin is converted by the alliinase enzyme into allicin which is responsible for the aroma of fresh garlic.
En outre, du fait de sa composition en alliine (près de 0,5 à 1,3% dans le bulbe) qui a des propriétés de captage du radical hydroxyle, l'ail s'est révélée avoir des propriétés antioxydantes très intéressantes. Maintenant, celles-ci sont également associées pour partie aux flavonoïdes et au tocophérol que le bulbe d'ail renferme en quantités. In addition, because of its composition of alliine (nearly 0.5 to 1.3% in the bulb) which has properties of capturing the hydroxyl radical, garlic has been found to have very interesting antioxidant properties. Now, these are also associated in part with flavonoids and tocopherol that the bulb of garlic contains in quantities.
Avantageusement, la teneur de la composition selon l'invention en extrait de bulbe d'ail est comprise entre 0,01 et 0,5%, de préférence entre 0,01 et 0,05%. Advantageously, the content of the composition according to the invention in garlic bulb extract is between 0.01 and 0.5%, preferably between 0.01 and 0.05%.
FEU ILLE DE REM PLACEM ENT (RÈGLE 26)
Maintenant, et pour ce qui est de cet extrait de bulbe d'ail, on préférera utiliser un extrait sec, avantageusement désodorisé. FIRELIGHT OF REM PLACEM ENT (RULE 26) Now, and for this garlic bulb extract, it will be preferred to use a dry extract, advantageously deodorized.
Eri liën avec le brocoli (Brassica oleracea var. italica), il s'agit d'une variété de chou qui est originaire du sud de l'Italie. Le brocoli présente une tige centrale ferme ramifiée en petits bouquets qui, à la floraison, sont parsemés de minuscules fleurs jaunes. Habituellement de couleur vert foncé à vert sauge, le brocoli peut aussi être blanc ou pourpre (violacé). Eri lien with broccoli (Brassica oleracea var., Italica), it is a variety of cabbage that is native to southern Italy. Broccoli has a firm central stem branched into small bunches that, at bloom, are dotted with tiny yellow flowers. Usually dark green to sage green, broccoli can also be white or purple (purplish).
Pour ce qui est de ses propriétés, il bénéficie d'une action préventive du cancer (et principalement le cancer du côlon) grâce aux fibres et aux composés soufrés et d'autres antioxydants : indoles, sulforaphane, glutathion, quercétine, β-carotène, brocoline (alcaloïde typique du brocoli) : ces substances ont la propriété de neutraliser certains composés toxiques présents dans l'organisme (radicaux libres). In terms of its properties, it benefits from a preventive action against cancer (and mainly colon cancer) thanks to fibers and sulfur compounds and other antioxidants: indoles, sulforaphane, glutathione, quercetin, β-carotene, brocoline (alkaloid typical of broccoli): these substances have the property of neutralizing certain toxic compounds present in the body (free radicals).
Avantageusement, la teneur de la composition selon l'invention en extrait de brocoli ëst comprise entre 1 et 5%, de préférence entre 2 et 4%, voir entre 2,5 et 3%. Maintenant, et pour ce qui est de cet extrait de brocoli, on préférera utiliser un extrait sec, et surtout un extrait atomisé. Typiquement, cet extrait atomisé comprend des particules présentant un diamètre inférieur à 1 μπι. Advantageously, the content of the composition according to the invention in broccoli extract is between 1 and 5%, preferably between 2 and 4%, or between 2.5 and 3%. Now, and as for this broccoli extract, it will be preferred to use a dry extract, and especially an atomized extract. Typically, this atomized extract comprises particles having a diameter of less than 1 μπι.
La vitamine B6, elle, intervient dans le métabolisme de l'homocystéine dont la carence entraîne une baisse importante de la tonicité. En lien avec le système nerveux, la vitamine B6 participe également à la biosynthèse de la sérotonine et son apport journaliér recommandé (AJR) est de 1,4 mg selon la directive 2008/100/CE. Vitamin B 6 is involved in the metabolism of homocysteine whose deficiency causes a significant decrease in tone. In connection with the nervous system, vitamin B 6 also participates in the biosynthesis of serotonin and its recommended daily intake (RDA) is 1.4 mg according to the directive 2008/100 / CE.
De préférence, la composition selon l'invention présente une teneur en vitamine B6 est comprise entre 0,01 et 0,05%, de préférence entre 0,01 et 0,03%. Cette proportion est adaptée de sorte que la prise de la composition selon l'invention se rapproche de l'AJR sans risquer de (trop) l'excéder. Preferably, the composition according to the invention has a vitamin B 6 content is between 0.01 and 0.05%, preferably between 0.01 and 0.03%. This proportion is adapted so that the setting of the composition according to the invention is close to the AJR without risking (too) exceed it.
Par agent gélifiant, on entend un agent qui permette de donner à la composition selon l'invention la consistance d'un gel. "Gelling agent" means an agent which makes it possible to give the composition according to the invention the consistency of a gel.
De tels agents sont bien connus de l'homme du métier et comprennent notamment la gomme arabique (ou gomme d'acacia), la gomme xanthane, la gélatine, la pectine, les alginates, les carraghénanes, ou encore l'agar-agar. Such agents are well known to those skilled in the art and include gum arabic (or gum acacia), xanthan gum, gelatin, pectin, alginates, carrageenans, or agar agar.
FEUI LLE DE REM PLACEM ENT (RÈGLE 26)
La combinaison de gomme arabique et de gomme xanthane a montré, en lien avec la composition selon l'invention, une grande facilité de prise pour l'utilisateur et une assimilation rapide. FEUI LLE OF REM PLACEM ENT (RULE 26) The combination of gum arabic and xanthan gum has shown, in connection with the composition according to the invention, a great ease of grip for the user and rapid assimilation.
La teneur en agent gélifiant de la composition selon l'invention est dépendante de l'agent gélifiant utilisé et peut être simplement adaptée par l'homme du métier. Elle est typiquement supérieure à 0, 1% voir 0,5% et inférieure à 10% voir 5%. The content of gelling agent of the composition according to the invention is dependent on the gelling agent used and can be simply adapted by those skilled in the art. It is typically greater than 0.1%, 0.5% and less than 10% or 5%.
La composition selon l'invention pourra en outre comprendre différents constituants bénéficiant de propriétés antioxydantes ou stimulatrices. The composition according to the invention may further comprise different constituents with antioxidant or stimulating properties.
On ajoutera ainsi de préférence à cette dernière du sélénium, qui appartient à la famille des chalcogènes, de symbole Se et de numéro atomique 34. Thus selenium, which belongs to the family of chalcogenes, of symbol Se and atomic number 34 is preferably added to the latter.
Le sélénium est un oligo-élément constituant des sélénoprotéines dont fait partie le principaDantioxydant intracellulaire, la glutathion peroxydase. On en trouve dans les rognons de porc ourde bœuf, l'ail, le poisson et les mollusques. La nutrition occidentale satisfait largement les besoins quotidiens en cet élément mais il est impossible de prédire les concentrations corporelles de sélénium à partir de l'apport nutritionnel parce que son utilisation et sa rétention sont dépendantes de la présence d'acide folique, de vitamine B12 et négativement affectées par la présence d'homocystéine. Selenium is a trace element constituting selenoproteins including the intracellular principaDantioxidant, glutathione peroxidase. It is found in kidneys of pork, beef, garlic, fish and molluscs. Western nutrition largely meets the daily needs of this element, but it is impossible to predict body levels of selenium from dietary intake because its use and retention are dependent on the presence of folic acid, vitamin B12 and negatively affected by the presence of homocysteine.
Le sélénium utilisé se trouvera sous la forme d'un extrait de levure (ex. Saccharomyces cerevisiae) enrichi en sélénium. Cet enrichissement correspond à une concentration de l'ordre de 1 500 à 3 000 g de sélénium par gramme d'extrait. The selenium used will be in the form of a yeast extract (eg Saccharomyces cerevisiae) enriched in selenium. This enrichment corresponds to a concentration of the order of 1500 to 3000 g of selenium per gram of extract.
Il est a noter: que le sélénium présent dans cet extrait se trouve sous la forme de séléniométhionine et se présente sous la forme d'un extrait sec. It should be noted that the selenium present in this extract is in the form of seleniomethionine and is in the form of a dry extract.
Avantageusement, la teneur de la composition selon l'invention présente une teneur en extrait de levure enrichi en sélénium comprise entre est comprise entre 0,1 et 0,5%, de préférence entre 0, 1 et 0,3%. Advantageously, the content of the composition according to the invention has a content of yeast extract enriched with selenium between between 0.1 and 0.5%, preferably between 0.1 and 0.3%.
La composition selon l'invention comprendra en outre de préférence de la vitamine B9 qui est essentiel pour limiter le déclin cognitif et palier à l'apparition de pathologies 'liées à l'âge comme la maladie d'Alzheimer. L'apport journalier recommandé (AIR) en vitamine B est de 200 μg selon la directive 2008/100/CE. The composition according to the invention will further preferably comprise vitamin B 9 which is essential for limiting cognitive decline and for preventing the onset of age-related pathologies such as Alzheimer's disease. The recommended daily intake (AIR) of vitamin B is 200 μg according to Directive 2008/100 / EC.
FEU I LLE DE REM PLACEMENT (RÈG LE 26)
De préférence, la composition selon l'invention présente une teneur en vitamine B9 comprise entre est comprise entre 0,001 et 0,005%, de préférence entre 0,001 et 0,003%. Cette proportion est adaptée de sorte que la prise de la composition selon l'invention se rapproche de l'AIR sans risquer de (trop) l'excéder. La composition selon l'invention pourra comprendre en outre des acidifiants, parmi lesquels l'acide citrique. FIREPLACE REMPLACEMENT (RULE 26) Preferably, the composition according to the invention has a vitamin B 9 content between 0.001 and 0.005%, preferably between 0.001 and 0.003%. This proportion is adapted so that the setting of the composition according to the invention is close to the AIR without risking to (excessively) exceed it. The composition according to the invention may furthermore comprise acidifiers, among which citric acid.
La teneur en acidifiant de la composition selon l'invention pourra atteindre les 2%, mais sera préférentiellement inférieure ou égale à 1%. The acidifying content of the composition according to the invention may reach 2%, but will preferably be less than or equal to 1%.
De même, la composition selon l'invention pourra comprendre au moins un édulcorant. A titre d'exemple de tels édulcorants, on pourra citer, entre autres, le sucralose, l'extrait .de stévia, le xylitol, l'aspartame, le sirop de glucose, le sirop de fructo-oligosaccharide, le maltitol en poudre ou en sirop, l'acésulfame de potassium, le fructooligosaccharide et le cyclamate de sodium. Similarly, the composition according to the invention may comprise at least one sweetener. Examples of such sweeteners include, among others, sucralose, stevia extract, xylitol, aspartame, glucose syrup, fructooligosaccharide syrup, maltitol powder or syrup, acesulfame potassium, fructooligosaccharide and sodium cyclamate.
La composition selon l'invention comprendra en outre au moins un conservateur. A titre d'exemples de conservateurs, on pourra citer le sorbate de potassium, le benzoate de sodium ou le palmitate d'ascorbyle (antioxydant). The composition according to the invention will also comprise at least one preservative. As examples of preservatives, mention may be made of potassium sorbate, sodium benzoate or ascorbyl palmitate (antioxidant).
Enfin, la composition selon l'invention pourra comprendre un agent texturant tel que la glycérine. Finally, the composition according to the invention may comprise a texturing agent such as glycerine.
Un second objet de l'invention porte sur une dosette contenant la composition sous forme de gel selon l'invention. A second subject of the invention relates to a pod containing the composition in gel form according to the invention.
L'utilisateur; -pourra ainsi consommer simplement la dose requise et, s'il le souhaite, l'associer ou la dissoudre dans un verre d'eau. The user; and can simply consume the required dose and, if desired, combine or dissolve in a glass of water.
Un troisième objet selon l'invention correspond à l'utilisation d'une composition telle que décrite précédemment pour la prévention de pathologies associées à des dommages oxydatifs dus aux radicaux libres, tels que les cancers, chez un sujet. A third object according to the invention corresponds to the use of a composition as described above for the prevention of pathologies associated with oxidative damage due to free radicals, such as cancers, in a subject.
Par cancer; on entend de préférence un cancer oral ou un cancer de l'appareil digestif. By cancer; oral cancer or cancer of the digestive tract is preferably meant.
Les exemples ci-après sont fournis pour illustrer l'invention et ne doivent en aucun cas être considérés comme une limite à la portée de l'invention. The following examples are provided to illustrate the invention and should in no way be considered as a limit to the scope of the invention.
FEU I LLE DE REM PLACEMENT (RÈG LE 26)
FIREPLACE REMPLACEMENT (RULE 26)
Claims
1. Une composition alimentaire sous forme de gel, laquelle comprend au moins : 1. A food composition in gel form, which comprises at least:
un extrait de rhizome de curcuma dont la teneur est comprise entre 1 et 3% ; an extract of turmeric rhizome having a content of between 1 and 3%;
un extrait de fleurs de Sophora du Japon dont la teneur est comprise entre 1 et 3%; an extract of Japanese Sophora flowers with a content of between 1 and 3%;
un extrait de grenade dont la teneur est comprise entre 2 et 10% ; un extrait de thé vert dont la teneur est comprise entre 1 et 5% ; un extrait de bulbe d'ail dont la teneur est comprise entre 0,01 et 0,5%; a pomegranate extract whose content is between 2 and 10%; a green tea extract whose content is between 1 and 5%; an extract of garlic bulb whose content is between 0.01 and 0.5%;
un extrait de brocoli dont la teneur est comprise entre 1 et 5% ; de la vitamine B6 dont la teneur est comprise entre 0,01 et 0,05%; et a broccoli extract with a content of between 1 and 5%; vitamin B6, the content of which is between 0.01 and 0.05%; and
un agent gélifiant dont la teneur est comprise entre 0,1 et 10%. a gelling agent whose content is between 0.1 and 10%.
2. La composition selon la revendication 1, laquelle comprend en outre du sélénium sous la forme d'un extrait de levure enrichi en sélénium et dont la teneur est comprise entre 0,1 et 0,5%. 2. The composition according to claim 1, which further comprises selenium in the form of a yeast extract enriched with selenium and whose content is between 0.1 and 0.5%.
3. La composition selon l'une quelconque des revendications précédentes, dans laquelle l'extrait de grenade est un jus de grenade. The composition of any of the preceding claims, wherein the pomegranate extract is a pomegranate juice.
4. La composition selon l'une quelconque des revendications précédentes, dans laquelle l'extrait de bulbe d'ail est un extrait sec, avantageusement désodorisé. 4. The composition according to any one of the preceding claims, wherein the garlic bulb extract is a dry extract, advantageously deodorized.
5. La composition selon l'une quelconque des revendications précédentes, dans laquelle l'extrait de brocoli est un extrait sec, avantageusement atomisé.
5. The composition according to any one of the preceding claims, wherein the broccoli extract is a dry extract, advantageously atomized.
6. La composition selon l'une quelconque des revendications précédentes, dans laquelle l'agent gélifiant est choisi dans le groupe comprenant la gomme arabique, la gomme xanthane, la gélatine, la pectine, les alginates, les carraghénanes et Pagar-agar. 6. The composition according to any one of the preceding claims, wherein the gelling agent is selected from the group consisting of gum arabic, xanthan gum, gelatin, pectin, alginates, carrageenans and agar-agar.
7. La composition selon l'une quelconque des revendications précédentes, laquelle comprend en outre de la vitamine B9. The composition of any one of the preceding claims, which further comprises vitamin B9.
8. Une dosette contenant la composition selon l'une quelconque des revendications 1 à 7. 8. A pod containing the composition according to any one of claims 1 to 7.
9. Une composition selon l'une quelconque des revendications 1 à 7 destinée à la prévention de pathologies associées à des dommages oxydatifs dus aux radicaux libres tels que les cancers.
9. A composition according to any one of claims 1 to 7 for the prevention of pathologies associated with oxidative damage due to free radicals such as cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1402031A FR3025722A1 (en) | 2014-09-11 | 2014-09-11 | ANTIOXIDIZING FOOD COMPOSITION IN THE FORM OF GEL |
FR14/02031 | 2014-09-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016037698A1 true WO2016037698A1 (en) | 2016-03-17 |
Family
ID=51905183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2015/001807 WO2016037698A1 (en) | 2014-09-11 | 2015-09-08 | Antioxidant food composition in gel form |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3025722A1 (en) |
WO (1) | WO2016037698A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201700048596A1 (en) * | 2017-05-05 | 2018-11-05 | Gabriele Bilancini | Composition based on turmeric extracts |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090087501A1 (en) * | 2007-10-01 | 2009-04-02 | Colgate-Palmolive Company | Oral Compositions Containing Botanical Extracts |
CN103734344A (en) * | 2013-12-19 | 2014-04-23 | 芜湖中路实业有限责任公司 | Healthcare garlic soybean milk and preparation method thereof |
-
2014
- 2014-09-11 FR FR1402031A patent/FR3025722A1/en active Pending
-
2015
- 2015-09-08 WO PCT/EP2015/001807 patent/WO2016037698A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090087501A1 (en) * | 2007-10-01 | 2009-04-02 | Colgate-Palmolive Company | Oral Compositions Containing Botanical Extracts |
CN103734344A (en) * | 2013-12-19 | 2014-04-23 | 芜湖中路实业有限责任公司 | Healthcare garlic soybean milk and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Week 201442, Derwent World Patents Index; AN 2014-L39228, XP002749035 * |
SANJAY KUMAR ET AL: "Therapeutic Plants of Ayurveda; A Review on Anticancer", PHARMACOGNOSY JOURNAL, vol. 3, no. 23, 1 July 2011 (2011-07-01), pages 1 - 11, XP055188892, ISSN: 0975-3575, DOI: 10.5530/pj.2011.23.1 * |
YOSHIMI NIWANO ET AL: "Extensive screening for herbal extracts with potent antioxidant properties", JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, vol. 48, no. 1, 1 January 2010 (2010-01-01), pages 78 - 84, XP055188875, ISSN: 0912-0009, DOI: 10.3164/jcbn.11-013FR * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201700048596A1 (en) * | 2017-05-05 | 2018-11-05 | Gabriele Bilancini | Composition based on turmeric extracts |
WO2018203195A1 (en) * | 2017-05-05 | 2018-11-08 | Bilancini Gabriele | Turmeric extracts based compositions |
Also Published As
Publication number | Publication date |
---|---|
FR3025722A1 (en) | 2016-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Almeida et al. | Properties and applications of Morinda citrifolia (noni): A review | |
Burris et al. | Composition and bioactive properties of yerba mate (Ilex paraguariensis A. St.-Hil.): a review | |
Bastos et al. | Yerba mate: pharmacological properties, research and biotechnology | |
Nadeem et al. | Antioxidant potential of bell pepper (Capsicum annum L.)-A review | |
Mirzaei-Aghsaghali | Importance of medical herbs in animal feeding: A review | |
JP4229942B2 (en) | Fat metabolism promoter or anti-diabetic agent | |
Prabu et al. | Phytopharmacological potential of the natural gift Moringa oleifera Lam and its therapeutic application: An overview | |
KR101861796B1 (en) | An antioxidant composition comprising platycodon grandiflorum extract | |
US20200197356A1 (en) | Compositions With Ketogenic Agents, Cannabinoids, Plant- Derived Substances And Micronutrients | |
WO2017072219A1 (en) | Specific nutritional or therapeutic agent including a mixture of grape and blueberry | |
Qiblawi et al. | Chemopreventive effect of cardamom (Elettaria cardamomum L.) against benzo (α) pyrene-induced forestomach papillomagenesis in swiss albino mice | |
JP2006212021A (en) | Food composition | |
FR2899768A1 (en) | Food supplement, useful as antioxidant, to improve the organ response or prevent the oxidative stress and to reduce aging, comprises gamma-tocopherol, flavonoids, carnosic acid and carnosol | |
Kasali et al. | Chemical constituents and evidence-based pharmacological properties of Physalis peruviana L.: An overview | |
WO2016037698A1 (en) | Antioxidant food composition in gel form | |
Wojewoda et al. | Analysis of content of steviosides as biologically active compounds in stevia (Stevia rebaudiana) and products manufactured on the basis of this plant | |
EP3405207B1 (en) | Detoxifying composition for oral administration and method for preparing same | |
WO2015024577A2 (en) | Novel safranal-based composition | |
KR101878412B1 (en) | Traditional health tea using onion skin and natural materials and its manufacturing method | |
Bajaj et al. | A review on antioxidant activity of coffee and its additives | |
WO2021064167A1 (en) | Combination product for relieving the bronchi | |
KR20110037020A (en) | The anti-diabetes composition containing silkworm culturing product and medicinal herbs | |
Lim | Lepidium meyenii | |
FR3017029A1 (en) | ACTIVE NUTRITIONAL PRINCIPLE OBTAINED FROM ANGUSTIFOLIUM VACCINE, COMPOSITION CONTAINING THE SAME AND USE THEREOF | |
Yang et al. | Green sweet potato leaves increase Nrf2-mediated antioxidant activity and facilitate benzo [a] pyrene metabolism in the liver by increasing phase II detoxifying enzyme activities in rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15770791 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15770791 Country of ref document: EP Kind code of ref document: A1 |